Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications

被引:0
作者
Weiyue Zhang
Xin Huang
机构
[1] Union Hospital,Department of Endocrinology
[2] Tongji Medical College,Department of Orthopaedics
[3] Huazhong University of Science and Technology,undefined
[4] Union Hospital,undefined
[5] Tongji Medical College,undefined
[6] Huazhong University of Science and Technology,undefined
来源
Inflammation and Regeneration | / 43卷
关键词
Stem cell; Drug delivery strategy; Cell membrane-coating nanotechnology; Skin regeneration; Wound healing;
D O I
暂无
中图分类号
学科分类号
摘要
Stem cell-based therapy is widely accepted to be a promising strategy in tissue regenerative medicine. Nevertheless, there are several obstacles to applying stem cells in skin regeneration and wound healing, which includes determining the optimum source, the processing and administration methods of stem cells, and the survival and functions of stem cells in wound sites. Owing to the limitations of applying stem cells directly, this review aims to discuss several stem cell-based drug delivery strategies in skin regeneration and wound healing and their potential clinical applications. We introduced diverse types of stem cells and their roles in wound repair. Moreover, the stem cell-based drug delivery systems including stem cell membrane-coated nanoparticles, stem cell-derived extracellular vesicles, stem cell as drug carriers, scaffold-free stem cell sheets, and stem cell-laden scaffolds were further investigated in the field of skin regeneration and wound healing. More importantly, stem cell membrane-coating nanotechnology confers great advantages compared to other drug delivery systems in a broad field of biomedical contexts. Taken together, the stem cell-based drug delivery strategy holds great promise for treating skin regeneration and wound healing.
引用
收藏
相关论文
共 350 条
[31]  
Stojadinovic O(2016)A facile approach to functionalize cell membrane-coated nanoparticles Theranostics 6 600-82
[32]  
Nourian Dehkordi A(2015)Cell membrane-camouflaged nanoparticles for drug delivery J Control Release 220 3436-457
[33]  
Mirahmadi Babaheydari F(2015)Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia ACS Nano 9 211-676
[34]  
Chehelgerdi M(2022)A nanodrug coated with membrane from brain microvascular endothelial cells protects against experimental cerebral malaria Nano Lett 22 1800016-2385
[35]  
Raeisi DS(2018)Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection Adv Ther (Weinh) 1 5196-340
[36]  
Butler KL(2020)Transplantation of hPSC-derived pericyte-like cells promotes functional recovery in ischemic stroke mice Nat Commun 11 9808-1029
[37]  
Goverman J(2021)Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles ACS Nano 15 1176-1630
[38]  
Ma H(2016)Polymer-DNA nanoparticle-induced CXCR4 overexpression improves stem cell engraftment and tissue regeneration in a mouse hindlimb ischemia model Theranostics 6 300-4598
[39]  
Fischman A(2013)CXCL12/CXCR4 signaling and other recruitment and homing pathways in fracture repair Bonekey Rep 2 135-136
[40]  
Yu YM(2007)Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2 J Cell Biochem 101 1370-2389